ChromeMate, a patented oxygen-coordinated, niacin-bound chromium, demonstrated its ability to prolong the life span of test animals by more than +22 percent. The study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center ( Omaha, NE), was presented at the 46th Annual Meeting of the American College of Nutrition, September 22-25, 2005, in Kiawah Island, South Carolina. Rats prone to aging were fed diets containing ChromeMate, which increased their average life span by +22% compared to rats fed the same diet without ChromeMate.
Rats fed ChromeMate also experienced:
- Lower systolic blood pressure
- Lower circulating glucose levels
- Lower, normalized hemoglobin levels, a long-term indicator of blood sugar status.
- No abnormalities in blood chemistry, kidney or liver function
The first death in the ChromeMate group did not occur until week 59, while the first death in the control (placebo) group occurred at week 47. Thirty three percent of the animals in the ChromeMate group lived at least one month beyond the last animal in the control group. "We've long known that niacin-bound chromium provides significant health benefits relative to metabolic syndrome," stated lead researcher, Harry G. Preuss, M.D. from Georgetown University Medical Center. "These new results open the possibility that ChromeMate niacin-bound chromium may prolong human life as well." Generically known as chromium nicotinate or chromium polynicotinate, ChromeMate is a unique oxygen-coordinated niacin-bound chromium complex that plays an important role in proper insulin function, maintenance of healthy blood sugar and cholesterol levels, normal energy production, and promotion of healthy body weight.
